Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2024, Vol. 38 ›› Issue (6): 55-60.doi: 10.6040/j.issn.1673-3770.0.2023.343
• Research Progress • Previous Articles
ZHOU Shitong1,2, YANG Yanyan1, YANG Yucheng2, FANG Hongyan1
CLC Number:
[1] 中华耳鼻咽喉头颈外科杂志编辑委员会咽喉组,中华医学会耳鼻咽喉头颈外科学分会咽喉学组,中华医学会耳鼻咽喉头颈外科学分会嗓音学组.咽喉反流性疾病诊断与治疗专家共识(2022年,修订版)[J].中华耳鼻咽喉头颈外科杂志, 2022, 57(10): 1149-1172. doi:10.3760/cma.j.cn115330-20220711-00428 Subspecialty Group of Laryngopharyngology,Editorial Board of Chinese Journal of Otorhinolaryngology Head and Neck Surgery; Subspecialty Group of Laryngopharyngology,Society of Otorhinolaryngology Head and Neck Surgery,Chinese Medical Association;Subspecialty Group of Voice,Society of Otorhinolaryngology Head and Neck Surgery,Chinese Medical Association. Experts consensus on diagnosis and treatment of laryngopharyngeal reflux disease(2022,revision)[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2022, 57(10): 1149-1172. doi:10.3760/cma.j.cn115330-20220711-00428 [2] Lechien JR, Akst LM, Hamdan AL, et al. Evaluation and management of laryngopharyngeal reflux disease: state of the art review[J]. Otolaryngol Head Neck Surg, 2019, 160(5): 762-782. doi:10.1177/0194599819827488 [3] 曾宪廷,王广科,孙占伟,等. 伴咽喉反流的难治性鼻窦炎术后应用质子泵抑制剂的疗效观察[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 189-194. doi:10.6040/j.issn.1673-3770.0.2021.512 ZENG Xianting, WANG Guangke, SUN Zhanwei, et al. Postoperative efficacy of proton pump inhibitor in the treatment of difficult-to-treat rhinosinusitis with laryngopharyngeal reflux[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 189-194. doi:10.6040/j.issn.1673-3770.0.2021.512 [4] Barsouk A, Aluru JS, Rawla P, et al. Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma[J]. Med Sci(Basel), 2023, 11(2): 42. doi: 10.3390/medsci11020042 [5] Du E, Mazul AL, Farquhar D, et al. Long-term survival in head and neck cancer: impact of site, stage, smoking, and human papillomavirus status[J]. Laryngoscope, 2019, 129(11): 2506-2513. doi:10.1002/lary.27807 [6] Wang SM, Freedman ND, Katki HA, et al. Gastroesophageal reflux disease: a risk factor for laryngeal squamous cell carcinoma and esophageal squamous cell carcinoma in the NIH-AARP diet and health study cohort[J]. Cancer, 2021, 127(11): 1871-1879. doi: 10.1002/cncr.33427 [7] Parsel Sean M,Iarocci Andrew L,Gasta?aduy Mariella et al. Reflux Disease and Laryngeal Neoplasia in Nonsmokers and Nondrinkers.[J].Otolaryngol Head Neck Surg, 2020, 163: 560-562.doi:10.1177/0194599820917669 [8] Krause AJ, Walsh EH, Weissbrod PA, et al. An update on current treatment strategies for laryngopharyngeal reflux symptoms[J]. Ann N Y Acad Sci, 2022, 1510(1): 5-17. doi:10.1111/nyas.14728 [9] Mishra P, Agrawal D, Chauhan K, et al. Prevalence of laryngopharyngeal reflux disease in Indian population[J]. Indian J Otolaryngol Head Neck Surg, 2022,74(2):1877-1881. doi:10.1007/s12070-020-01882-1 [10] Salihefendic N, Zildzic M, Cabric E. Laryngopharyngeal reflux disease-LPRD[J]. Med Arch, 2017, 71(3): 215-218. doi:10.5455/medarh.2017.71:215-218 [11] Kanemitsu Y, Kurokawa R, Takeda N, et al. Clinical impact of gastroesophageal reflux disease in patients with subacute/chronic cough[J]. Allergol Int, 2019, 68(4): 478-485. doi:10.1016/j.alit.2019.04.011 [12] 邵娜, 张青青, 刘小红, 等. 幽门螺旋杆菌感染对症状性咽喉反流患者唾液胃蛋白酶浓度的影响[J]. 山东大学耳鼻喉眼学报, 2022, 36(6): 89-95. doi:10.6040/j.issn.1673-3770.0.2022.350 SHAO Na, ZHANG Qingqing, LIU Xiaohong, et al. Effects of Helicobacter pylori infection on salivary pepsin concentration in patients with symptomatic laryn-gopharyngeal reflux[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(6): 89-95. doi:10.6040/j.issn.1673-3770.0.2022.350 [13] 李超凡, 张立红, 王文伦, 等. 耳鼻咽喉科门诊患者咽喉反流性疾病、焦虑抑郁患病率及二者关系[J]. 中华耳鼻咽喉头颈外科杂志, 2020, 55(3): 241-248. doi:10.3760/cma.j.issn.1673-0860.2020.03.010 LI Chaofan, ZHANG Lihong, WANG Wenlun, et al. The prevalence and relationship between laryngopharyngeal reflux disease, anxiety and depression in otolaryngology outpatients[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2020, 55(3): 241-248. doi:10.3760/cma.j.issn.1673-0860.2020.03.010 [14] 崔小缓, 张延平, 阎小妍, 等. 耳鼻咽喉科门诊成年患者的睡眠状况与咽喉反流性疾病的相关性[J]. 中华耳鼻咽喉头颈外科杂志, 2019, 54(10): 754-759. doi:10.3760/cma.j.issn.1673-0860.2019.10.009 CUI Xiaohuan, ZHANG Yanping, YAN Xiaoyan, et al. Relationship between sleep status and laryngopharyngeal reflux disease in adult patients in otolaryngology clinic[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2019, 54(10): 754-759. doi:10.3760/cma.j.issn.1673-0860.2019.10.009 [15] 张晨彬, 李木, 张延平, 等. 慢性睡眠剥夺和高脂饮食与咽喉反流性疾病相关性的实验研究[J]. 听力学及言语疾病杂志, 2018, 26(1): 68-72. doi:10.3969/j.issn.1006-7299.2018.01.018 ZHANG Chenbin, LI Mu, ZHANG Yanping, et al. Upper gastrointestinal tract pH monitoring in rats with chronic sleep deprivation and high fat diet[J]. Journal of Audiology and Speech Pathology, 2018, 26(1): 68-72. doi:10.3969/j.issn.1006-7299.2018.01.018 [16] Gtari W, Bey H, Aschi A, et al. Impact of macromolecular crowding on structure and properties of pepsin and trypsin[J]. Mater Sci Eng C Mater Biol Appl, 2017, 72: 98-105. doi:10.1016/j.msec.2016.11.046 [17] Bardhan KD, Strugala V, Dettmar PW. Reflux revisited: advancing the role of pepsin[J]. Int J Otolaryngol, 2012: 646901. doi: 10.1155/2012/646901 [18] Tamhankar AP, Peters JH, Portale G, et al. Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology[J]. J Gastrointest Surg, 2004, 8(7): 890-898. doi: 10.1016/j.gassur.2004.08.001 [19] Wang L, Liu X, Liu YL, et al. Correlation of pepsin-measured laryngopharyngeal reflux disease with symptoms and signs[J]. Otolaryngol Head Neck Surg, 2010, 143(6):765-771. doi: 10.1016/j.otohns.2010.08.018 [20] Pizzorni N, Ambrogi F, Eplite A, et al. Magnesium alginate versus proton pump inhibitors for the treatment of laryngopharyngeal reflux: a non-inferiority randomized controlled trial[J]. Eur Arch Otorhinolaryngol, 2022, 279(5): 2533-2542. doi:10.1007/s00405-021-07219-0 [21] Eells AC, MacKintosh C, Marks L, et al. Gastroesophageal reflux disease and head and neck cancers: a systematic review and meta-analysis[J]. Am J Otolaryngol, 2020, 41(6): 102653. doi:10.1016/j.amjoto.2020.102653 [22] Blaine-Sauer S, Samuels TL, Yan K, et al. The protease inhibitor amprenavir protects against pepsin-induced esophageal epithelial barrier disruption and cancer-associated changes[J]. Int J Mol Sci, 2023, 24(7): 6765. doi: 10.3390/ijms24076765 [23] Calvo-Henríquez C, Ruano-Ravina A, Vaamonde P, et al. Is pepsin a reliable marker of laryngopharyngeal reflux? A systematic review[J]. Otolaryngol Head Neck Surg, 2017, 157(3): 385-391. doi:10.1177/0194599817709430 [24] Katzka DA, Kahrilas PJ. Advances in the diagnosis and management of gastroesophageal reflux disease[J]. BMJ, 2020, 371: m3786. doi:10.1136/bmj.m3786 [25] Bevilacqua LA, Obeid NR, Yang J, et al. Incidence of GERD, esophagitis, Barrett’s esophagus, and esophageal adenocarcinoma after bariatric surgery[J]. Surg Obes Relat Dis, 2020, 16(11): 1828-1836. doi:10.1016/j.soard.2020.06.016 [26] Gong X, Wang XY, Yang L, et al. Detecting laryngopharyngeal reflux by immunohistochemistry of pepsin in the biopsies of vocal fold leukoplakia[J]. J Voice, 2018, 32(3): 352-355. doi:10.1016/j.jvoice.2017.06.010 [27] Sezen Goktas S, Dogan R, Yenigun A, et al. A new approach to vocal cord leukoplakia and evaluation of proton pump ınhibitor treatment[J]. Eur Arch Otorhinolaryngol, 2019, 276(2): 467-471. doi:10.1007/s00405-018-05273-9 [28] Parsel SM, Wu EL, Riley CA, et al. Gastroesophageal and laryngopharyngeal reflux AssociatedWith laryngeal malignancy: a systematic reviewand meta-analysis[J]. Clin Gastroenterol Hepatol, 2019, 17(7): 1253-1264. doi:10.1016/j.cgh.2018.10.028 [29] Yin CY, Zhang SS, Zhong JT, et al. Pepsin and laryngeal and hypopharyngeal carcinomas[J]. Clin Exp Otorhinolaryngol, 2021, 14(2): 159-168. doi:10.21053/ceo.2020.00465 [30] Lagergren J, Lindam A. Increased risk of laryngeal and pharyngeal cancer after gastrectomy for ulcer disease in a population-based cohort study[J]. Br J Cancer, 2012, 106(7): 1342-1345. doi:10.1038/bjc.2012.72 [31] 谭嘉杰, 王路, 黄祚峰, 等. 胃蛋白酶在喉癌组织中的表达和意义[J]. 中华耳鼻咽喉头颈外科杂志, 2016, 51(8): 593-599. doi:10.3760/cma.j.issn.1673-0860.2016.08.007 TAN Jiajie, WANG Lu, HUANG Zuofeng, et al. The expression and significance of pepsin in laryngeal carcinoma[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2016, 51(8): 593-599. doi:10.3760/cma.j.issn.1673-0860.2016.08.007 [32] Niu K, Guo CJ, Teng SY, et al. Pepsin promotes laryngopharyngeal neoplasia by modulating signaling pathways to induce cell proliferation[J]. PLoS One, 2020, 15(1): e0227408. doi:10.1371/journal.pone.0227408 [33] Johnston N, Dettmar PW, Lively MO, et al. Effect of pepsin on laryngeal stress protein(Sep70, Sep53, and Hsp70)response: role in laryngopharyngeal reflux disease[J]. Ann Otol Rhinol Laryngol, 2006, 115(1): 47-58. doi:10.1177/000348940611500108 [34] Ali MELS, Bulmer DM, Dettmar PW, et al. Mucin gene expression in reflux laryngeal mucosa: histological and in situ hybridization observations[J]. Int J Otolaryngol, 2014, 2014: 264075. doi:10.1155/2014/264075 [35] Johnston N, Wells CW, Samuels TL, et al. Pepsin in nonacidic refluxate can damage hypopharyngeal epithelial cells[J]. Ann Otol Rhinol Laryngol, 2009, 118(9): 677-685. doi:10.1177/000348940911800913 [36] Komatsu Y, Kelly LA, Zaidi AH, et al. Hypopharyngeal pepsin and Sep70 as diagnostic markers of laryngopharyngeal reflux: preliminary study[J]. Surg Endosc, 2015, 29(5): 1080-1087. doi:10.1007/s00464-014-3789-y [37] Chaudhari M, Jayaraj R, Bhaskar AS, et al. Oxidative stress induction by T-2 toxin causes DNA damage and triggers apoptosis via caspase pathway in human cervical cancer cells[J]. Toxicology, 2009, 262(2): 153-161. doi:10.1016/j.tox.2009.06.002 [38] Samuels TL, Johnston N. Pepsin as a causal agent of inflammation during nonacidic reflux[J]. Otolaryngol Head Neck Surg, 2009, 141(5): 559-563. doi:10.1016/j.otohns.2009.08.022 [39] Sandner A, Illert J, Koitzsch S, et al. Reflux induces DNA strand breaks and expression changes of MMP1+9+14 in a human miniorgan culture model[J]. Exp Cell Res, 2013, 319(19): 2905-2915. doi:10.1016/j.yexcr.2013.09.004 [40] Sasaki CT, Toman J, Vageli D. The in vitro effect of acidic-pepsin on nuclear factor KappaB activation and its related oncogenic effect on normal human hypopharyngeal cells[J]. PLoS One, 2016, 11(12): e0168269. doi:10.1371/journal.pone.0168269 [41] 刘倩, 吕颜露. 咽喉反流通过NF-κB信号通路介导炎症反应对声带黏膜的影响[J]. 华中科技大学学报(医学版), 2019, 48(1): 32-37. doi:10.3870/j.issn.1672-0741.2019.01.006 LIU Qian, LV Yanlu. Effect of laryngopharyngeal reflux on vocal cord mucosa via inflammatory response mediated by NF-κB signaling pathway[J]. Acta Medicinae Universitatis Scientiae et Technologiae Huazhong, 2019, 48(1): 32-37. doi:10.3870/j.issn.1672-0741.2019.01.006 [42] Kunze B, Wein F, Fang HY, et al. Notch signaling mediates differentiation in barrett’s esophagus and promotes progression to adenocarcinoma[J]. Gastroenterology, 2020, 159(2): 575-590. doi:10.1053/j.gastro.2020.04.033 [43] Doukas PG, Vageli DP, Sasaki CT, et al. Pepsin promotes activation of epidermal growth factor receptor and downstream oncogenic pathways, at slightly acidic and neutral pH, in exposed hypopharyngeal cells[J]. Int J Mol Sci, 2021, 22(8): 4275. doi:10.3390/ijms22084275 [44] Adams J, Heintz P, Gross N, et al. Acid/pepsin promotion of carcinogenesis in the hamster cheek pouch[J]. Arch Otolaryngol Head Neck Surg, 2000, 126(3): 405-409. doi:10.1001/archotol.126.3.405 [45] Johnston N, Yan JC, Hoekzema CR, et al. Pepsin promotes proliferation of laryngeal and pharyngeal epithelial cells[J]. Laryngoscope, 2012, 122(6): 1317-1325. doi:10.1002/lary.23307 [46] Tan JJ, Wang L, Mo TT, et al. Pepsin promotes IL-8 signaling-induced epithelial-mesenchymal transition in laryngeal carcinoma[J]. Cancer Cell Int, 2019, 19: 64. doi:10.1186/s12935-019-0772-7 [47] Choudhary MM, France TJ, Teknos TN, et al. Interleukin-6 role in head and neck squamous cell carcinoma progression[J]. World J Otorhinolaryngol Head Neck Surg, 2016, 2(2): 90-97. doi:10.1016/j.wjorl.2016.05.002 [48] Rébé C, Ghiringhelli F. Interleukin-1β and cancer[J]. Cancers, 2020, 12(7): 1791. doi:10.3390/cancers12071791 [49] Wood JM, Hussey DJ, Woods CM, et al. Does gene expression in laryngeal subsites differ between patients with laryngopharyngeal reflux and controls?[J]. Clin Otolaryngol, 2018, 43(1): 158-163. doi:10.1111/coa.12918 [50] Zhang F, Cao H. MicroRNA-143-3p suppresses cell growth and invasion in laryngeal squamous cell carcinoma via targeting the k-Ras/Raf/MEK/ERK signaling pathway[J]. Int J Oncol, 2019, 54(2): 689-701. doi:10.3892/ijo.2018.4655 |
[1] | WU Wei, WANG Lei, CHEN Sheng, LI Lianyong, WANG Gang. Multidisciplinary research and advances in gastro-oesophageal reflux disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 1-14. |
[2] | LIU Lianlian, LI Jinrang. Obstructive sleep apnea and laryngopharyngeal reflux [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 15-22. |
[3] | ZHANG Li, ZHANG Mengru, Alimire Aierken, QIU Zhongmin. Role of pharyngeal reflux in common respiratory diseases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 23-29. |
[4] | HU Zhiwei, CHEN Dong, YANG Dong, WU Jimin. Diagnosis and treatment of gastroesophageal airway reflux disease: based on related consensus and guidelines from 2020 to 2024 [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 30-38. |
[5] | ZHAO Jianing, CUI Yuanxin, WANG Dan, ZHAO Ming. Exploration of the relationship between laryngopharyngeal reflux and recurrent respiratory papilloma and its mechanism [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 39-45. |
[6] | ZHANG Shan, CHEN Qiu, ZHOU Fangwei, MA Yifei. Research progress of biomarkers in laryngopharyngeal reflux disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 46-54. |
[7] | NI Rongsheng, SHEN Xiaohui, GAO Xia. Correlation analysis of gene expression profile of matrix metalloproteinases and their inhibitors in laryngeal squamous cell carcinoma and clinicopathological features [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 55-61. |
[8] | WU Bin, ZHOU Jingchun. Single cell sequencing analysis of RPN2 expression pattern in laryngeal squamous cell carcinoma cells [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 1-11. |
[9] | WANG Kaijian, CHEN Xuesheng, WANG Wei. A meta-analysis of the correlation between platelet-lymphocyte ratio and prognosis of laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 67-73. |
[10] | XIE Yulin, LEI Dapeng. Advances in the pathological study of artificial intelligence in the lymph node metastasis of head and neck squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 124-129. |
[11] | SONG Fei, SONG Hao, LI Yumei, MOU Yakui, SONG Xicheng. Immunomodulatory roles of tumor-derived exosomes in the microenvironment of head and neck squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(1): 92-100. |
[12] | WANG Lei, LI Baowei, WANG Gang, LIU Hongdan, HAN Haolun, ZHANG Xiaoli, WU Wei. A preliminary study on nocturnal alkali reflux in OSAHS patients [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(6): 75-79. |
[13] | ZHANG Yonghong, ZHANG Hui, WANG Caihua, YANG Xinxin, WU Yungang, ZHAO Yufeng, PANG Taizhong, LI Xiaoyu. Construction of an immune-associated gene prognostic model and screening of targeted molecular drugs for laryngeal squamous cell carcinoma based on the TCGA database [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 54-62. |
[14] | ZHOU Xiaoqing, YAN Yajie, LI Yingchun. Treatment of hoarseness based on physiological function of the liver [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 74-79. |
[15] | ZHOU Yijing, ZOU Jianyin, YI Hongliang, WU Hongmin. Expression of TGFBI in head and neck squamous cell carcinoma and its clinical significance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 85-95. |
|